Second-hand smoke-induced cardiac fibrosis is related to the fas death receptor apoptotic pathway without mitochondria-dependent pathway involvement in rats

Environmental Health Perspectives

Volumn 113, Issue 10, 2005, Pages 1349-1353

  Kuo, Wei Wen ^a   Wu, Chieh Hsi ^a   Lee, Shin Da ^b   Lin, James A ^c   Chu, Chia Yih ^b   Hwang, Jin Ming ^b   Ueng, Kwo Chang ^b   Chang, Mu Hsin ^d   Yeh, Yu Lan ^e   Wang, Chau Jong ^b   Liu, Jer Liu ^b   Huang, Chih Yang ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Cardiac survival IGF 1 signalling; Caspases; Death receptor dependent pathway; Mitochondria dependent pathway; Second hand smoke (SHS)

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CIGARETTE SMOKE; DEATH RECEPTOR; FAS ANTIGEN; GELATINASE A; MESSENGER RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; MITOCHONDRIAL RESPIRATION; MOLECULAR MECHANICS; NONHUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; FIBROSIS; HEART DISEASES; INSULIN-LIKE GROWTH FACTOR I; MALE; MITOCHONDRIA; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOBACCO; TOBACCO SMOKE POLLUTION;

ANIMALIA; NICOTIANA TABACUM; RATTUS NORVEGICUS;

EID: 27244443037     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7479     Document Type: Article

References (36)

1. Anversa P, Kajstura J, Olivetti G. 1996. Myocyte death in heart failure. Curr Opin Cardiol 11(3):245-251.
2. Anversa P, Nadal-Ginard B. 2002. Myocyte renewal and ventricular remodelling. Nature 415(6868):240-243.
3. Baud FJ, Barriot P, Toffis V, Riou B, Vicaut E, Lecarpentier Y, et al. 1991. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 325(25):1761-1766.
4. Boyle P, Maisonneuve P. 1995. Lung cancer and tobacco smoking. Lung Cancer 12(3):167-181.
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. 1990. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67(6):1355-1364.
7. Bronnum-Hansen H. 2000. Predicted effect of smoking cessation of tobacco-related mortality [in Danish]. Ugeskr Laeger 162(43):5772-5777.
8. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. 2001. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276(13)-9817-9824.
9. Ciruzzi M, Pramparo P, Esteban O, Rozlosnik J, Tartaglione J, Abecasis B, et al. 1998. Case-control study of passive smoking at home and risk of acute myocardial infarction. Argentine FRICAS Investigators. Factores de Riesgo Coronario an America del Sur. J Am Coll Cardiol 31(4):797-803.
10. De Cosaris R, Ranieri G, Filitti V, Bonfantino MV, Andriani A. 1992. Cardiovascular effects of cigarette smoking. Cardiology 81(4-5):233-237.
11. Dollery CM, McEwan JR, Henney AM. 1995. Matrix metalloproteinases and cardiovascular disease. Circ Res 77(5):863-868.
12. Ecanow B, Blake MI. 1978. The hazard of particulates in tobacco smoke. N Engl J Med 299(25):1415-1416.
13. Fernandes-Alnemri T, Litwack G, Alnemri ES. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interieukin-1β-converting enzyme. J Biol Chem 269(49):30761-30764.
14. GenBank. 2004. Searching GenBank. Bethesda, MD:National Center for Biotechnology Information. Available: http://www.ncbi.nlm.nih.gov/Genbank/GenbankSearch.html [accessed 3 August 2005].
15. Haugen A. 2002. Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis 23(2):227-229.
16. Haunstetter A, Izumo S. 1998. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82(11):1111-1129.
17. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. 1998. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 273(13):7725-7730.
18. Huang CY, Kasai M, Buetow DE. 1998. Extremely-rapid RNA detection in dot blots with digoxigenin-labeled RNA probes. Genet Anal 14(4):109-112.
19. Institute of Laboratory Animal Resources. 1996. Guide for the Care and Use of Laboratory Animals. 7th ed. Washington, DC:National Academy Press.
20. Janicki JS, Brower GL, Henegar JR, Wang L. 1995. Ventricular remodeling in heart failure: the role of myocardial collagen. Adv Exp Med Biol 382:239-245.
21. Kim S, Iwao H. 2000. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52(1):11-34.
22. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1):147-157.
23. MacDougall JM, Dembroski TM, Slaats S, Herd JA, Eliot RS. 1983. Selective cardiovascular effects of stress and cigarette smoking. J Human Stress 9(3):13-21.
24. Makin GW, Corfe BM, Griffiths GJ, Thistlethwaite A, Hickman JA, Dive C. 2001. Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J 20(22):6306-6315.
25. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. 1996. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335(16):1182-1189.
26. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, et al. 1999. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96(14):8144-8149.
27. Pacifico A, Henry PD. 2003. Structural pathways and prevention of heart failure and sudden death. J Cardiovasc Electrophysiol 14(7):764-775.
28. Parrizas M, Saltiel AR, LeRoith D. 1997. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272(1):154-161.
29. Pope CA III, Eatough DJ, Gold DR, Pang Y, Nielsen KR, Nath P, et al. 2001. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect 109:711-716.
30. Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, et al. 1999. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J Biol Chem 274(39):27529-27535.
31. Reed JC, Paternostro G. 1999. Postmitochondrial regulation of apoptosis during heart failure. Proc Natl Acad Sci USA 96(14):7614-7616.
32. Scheubel RJ, Bartling B, Simm A, Silber RE, Drogaris K, Darmer D, et al. 2002. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? J Am Coll Cardiol 39(3):481-488.
33. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407(6803):538-541.
34. Stefanadis C, Vlachopoulos C, Tsiamis E, Diamantopoulos L, Toutouzas K, Giatrakos N, et al. 1998. Unfavorable effects of passive smoking on aortic function in men. Ann Intern Med 128(6):426-434.
35. Takemura G, Fujiwara H. 2003. Phenotype alterations of failing myocardium [in Japanese]. Nippon Rinsho 61(5):731-738.
36. Weber KT, Brilla CG, Campbell SE. 1992. Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies. Cardiology 81(4-5):266-273.